Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
about
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis.30 Years of the Mineralocorticoid Receptor: Mineralocorticoid receptor antagonists: 60 years of research and development.Genomic and rapid effects of aldosterone: what we know and do not know thus far.Progress in the Management of Primary Aldosteronism.
P2860
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@en
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@nl
type
label
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@en
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@nl
prefLabel
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@en
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@nl
P2093
P2860
P50
P356
P1476
Steroidal and Novel Non-steroi ...... mparison at Bench and Bedside.
@en
P2093
Christina Nowack
Peter Kolkhof
So-Young Kim
P2860
P304
P356
10.1007/164_2016_76
P577
2016-11-10T00:00:00Z